Page 3 - கைவினைஞர் கூட்டாளர்கள் வரையறுக்கப்பட்டவை கூட்டு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Major Shareholder Announcement Company Announcement Major shareholder announcement for Genmab A/S Copenhagen, Denmark; July 21, 2021 – Genmab A/S (Nasdaq: GMAB) announces under reference to Section 30 of the Danish Capital Markets Act that Artisan Partners Limited Partnership has informed us that, as of July 16, 2021, Artisan Partners Limited Partnership holds the voting rights to 3,261,591 shares in Genmab A/S, which amounts to 4.97% of the share capital and voting rights in Genmab A/S. About Genmab Genmab is an international biotechnology company with a core purpose to improve the lives of patients with cancer. Founded in 1999, Genmab is the creator of multiple approved antibody therapeutics that are marketed by its partners. The company aims to create, develop and commercialize differentiated therapies by leveraging next-generation antibody technologies, expertise in antibody

New jerseyUnited statesKalvebod bryggeMarisol peronAndrew carlsenArtisan partners limited partnershipExchange commissionGlobal investor relations communicationsCompany announcementDanish capital markets actSenior vice presidentGlobal investor relationsInvestor relationsVice presidentAnnual reportY shaped genmab